Fluidigm Fluidigm Q2 Revenues Grow 19 Percent The firm noted that its base product and service revenue (excluding COVID-19 testing) increased 33 percent year over year to $26.9 million. Fluidigm Inks Comarketing Pacts With Ultivue, ImaBiotech The separate comarketing agreements with Ultivue and ImaBiotech are related to Fluidigm's Imaging Mass Cytometry technology platform. GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases The GenomeWeb Index outperformed the Dow Jones, Nasdaq, and Nasdaq Biotechnology Index last month. GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. New Products Posted to GenomeWeb: Fluidigm, Waters, MicroGenDx, More May 6, 2021 Fluidigm Q1 Revenues Grow 19 Percent Mar 24, 2021 DARPA Programs Leveraging Host-Response Testing, CRISPR for Future Pandemic Preparedness Premium Mar 2, 2021 Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent Mar 1, 2021 FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit Feb 19, 2021 Fluidigm Loses Patent Suit Against IonPath Feb 11, 2021 Fluidigm CEO Lays Out Plan for 'Durable' Diagnostics, Clinical Business Post-COVID Premium Feb 10, 2021 Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth Jan 21, 2021 Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay Dec 18, 2020 People in the News: New Appointments at Fluidigm, Danaher, Guardant Health Nov 25, 2020 In Brief This Week: Fluidigm, Centogene, Ginkgo Bioworks, Applied DNA Sciences, More Nov 5, 2020 Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Oct 19, 2020 Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing Oct 8, 2020 Fluidigm to Offer Coronavirus Saliva Test to US Colleges, Universities at Low Cost Sep 29, 2020 Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production Sep 8, 2020 Fluidigm Raises $20.9M in Equity Offering, Will Receive $11M After Achieving NIH Milestone Sep 4, 2020 Stanford Team Develops Improved Approach for Single-Cell Metabolic Profiling Premium Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 26, 2020 Fluidigm Saliva Test for SARS-CoV-2 Gets FDA Emergency Use Authorization Aug 6, 2020 Fluidigm Q2 Revenues Fall 8 Percent but Beat Analysts' Estimates Load More Breaking News Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating Alternative Genetic Counseling Approach Leads to Higher Patient Satisfaction, Study Suggests The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.